Displaying items 13-24 of 141
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-12
•
Next >
-
Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline. The deal announced Monday will give Elan 21 percent of the future...Tags: Food and Drug Administration, Elan Corporation Plc, Moody's Corporation, Health Organizations, Theravance Incorporated
-
Wall St termina plano tras recientes máximos
ReutersPor Caroline Valetkevitch NUEVA YORK (Reuters) - Las acciones cerraron planas el lunes en la bolsa de Nueva York, tomándose un respiro tras trepar a máximos históricos la semana pasada, pero la fortaleza del sector cuidado de la salud ayudó a que los...Tags: S&P 500, Elan Corporation Plc, Financial Markets, Stock Market, Nasdaq Composite
-
Merck, Glaxo reducen precio de vacuna contra cáncer cervical para países pobres
ReutersPor Kate Kelland LONDRES, 9 mayo (Reuters) - Las farmacéuticas Merck y GlaxoSmithKline redujeron el precio de las vacunas contra el cáncer de cuello de útero en un acuerdo que les permitirá venderlas a los países más pobres por menos de 5 dó...Tags: Viral Diseases and Infections, Merck & Company Incorporated, HPV Vaccine
-
Elan alcanza acuerdo por regalías de 1.000 mln dlrs con Theravance
ReutersPor Padraic Halpin DUBLIN (Reuters) - Elan intensificó el lunes su intento por mantener su independencia al alcanzar un acuerdo de 1.000 millones de dólares para comprar el 21 por ciento de las regalías que la firma estadounidense Theravance recibe de...Tags: Elan Corporation Plc, Biogen Idec Incorporated, Theravance Incorporated
-
US STOCKS-Futures dip after record high; retail sales on tap
Reuters* Elan, Theravance reach royalties deal * Retail sales for April on tap * Futures off: Dow 40 pts, S&P 5.4 pts, Nasdaq 11.75 pts By Chuck Mikolajczak NEW YORK, May 13 (Reuters) - U.S. stock index futures dipped on Monday, indicating the S&P 500 may...Tags: S&P 500, Sprint Nextel Corporation, Elan Corporation Plc, Stock Market, Bird Flu
-
Elan's $1 billion drug royalty deal aids bid defense
ReutersDUBLIN (Reuters) - Irish drugmaker Elan Corporation has agreed a $1 billion royalties deal that could soothe concerns about its potentially risky acquisition strategy and fend off a takeover bid from Royalty Pharma. Elan, battling to keep its...Tags: Food and Drug Administration, Biogen Idec Incorporated, Shareholders, Theravance Incorporated, Thomson Corporation
-
Late payment costs European companies 350 billion euros
Reuters* European businesses forced to write off 3 pct of receivables * Late payment hitting southern Europe harder than the north * Business confidence down across Europe * European Union legislation not enough to help smaller firms By Clare Hutchison...Tags: European Union, Business, Bankruptcy, Economy, Business and Finance, Germany
-
Elan-Theravance deal a big boost for Baupost, Fidelity
ReutersBy Tim McLaughlin BOSTON, May 13 (Reuters) - Fidelity Investments and hedge fund Baupost Group LLC got a lift on Monday from their investment in Theravance Inc after the U.S.-based biopharmaceutical company agreed to a $1 billion royalty deal with...Tags: Warren Buffett, Elan Corporation Plc, Thomson Corporation, Theravance Incorporated
-
UPDATE 1-Elan strikes $1 bln royalty deal with Theravance
Reuters* Elan to acquire newly approved Breo as part of $1 bln deal * Irish drugmaker to announce further deals in due course * Looks to outmanoeuvre Royalty with second shareholder dividend By Padraic Halpin DUBLIN, May 13 (Reuters) - Elan stepped up its...Tags: Asthma, Food and Drug Administration, Multiple Sclerosis, COPD, Biogen Idec Incorporated
-
PRESS DIGEST-New York Times business news - May 10
ReutersMay 10 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * The Bank of Japan's efforts to reinvigorate the nation's economy are showing...Tags: Merck & Company Incorporated, Viral Diseases and Infections, The New York Times, Delta Air Lines, Japan
-
European shares dip from multi-year highs
ReutersPARIS, May 9 (Reuters) - European shares fell in early trade on Thursday, halting a sharp three-week rally to multi-year highs, with pharmaceutical stocks trimming recent lofty gains. GlaxoSmithKline and AstraZeneca were both down 0.5 percent. The sector...Tags: AstraZeneca Plc
-
JP Morgan, Greenhill advising GSK on sale of soft drinks brands
ReutersLONDON, May 2 (Reuters) - JP Morgan and Greenhill have been appointed to advise GlaxoSmithKline on the sale of its soft drinks brands Lucozade and Ribena, which analysts believe will fetch more than 1 billion pounds ($1.6 billion). A spokesman for...Tags: Japan, Bain Capital, LLC, Lion Capital Holdings, Deutsche Bank AG, United Kingdom
May 13, 2013
|Story| AP Broadcast
May 13, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 12, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.